Ligand validation:6REZ

LFA: EICOSANE

LFA is a Ligand Of Interest in 6REZ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Model completeness	Average occupancy
6REZ_LFA_A_305	29%	84%	0.123	0.863	0.32	0.44	-	-	0	55%	0.55
6REZ_LFA_A_301	24%	82%	0.266	0.917	0.31	0.48	-	-	2	90%	0.9
6REZ_LFA_B_301	22%	84%	0.306	0.951	0.29	0.46	-	-	0	85%	0.85
6REZ_LFA_C_305	19%	84%	0.254	0.888	0.33	0.43	-	-	0	80%	0.8
6REZ_LFA_C_306	18%	85%	0.151	0.826	0.28	0.45	-	-	0	50%	0.5
6REZ_LFA_B_302	18%	84%	0.263	0.866	0.31	0.45	-	-	2	90%	0.9
6REZ_LFA_C_303	17%	85%	0.16	0.829	0.29	0.45	-	-	0	50%	0.5
6REZ_LFA_A_304	14%	89%	0.221	0.912	0.28	0.36	-	-	0	25%	0.25
6REZ_LFA_B_306	14%	89%	0.212	0.893	0.28	0.36	-	-	1	30%	0.3
6REZ_LFA_E_304	14%	89%	0.176	0.864	0.28	0.35	-	-	0	25%	0.25
6REZ_LFA_C_301	14%	83%	0.32	0.883	0.31	0.47	-	-	1	95%	0.95
6REZ_LFA_E_307	14%	86%	0.145	0.792	0.3	0.41	-	-	0	45%	0.45
6REZ_LFA_E_308	13%	87%	0.24	0.876	0.3	0.4	-	-	0	45%	0.45
6REZ_LFA_E_305	12%	86%	0.189	0.803	0.3	0.42	-	-	0	50%	0.5
6REZ_LFA_D_305	10%	91%	0.224	0.852	0.31	0.28	-	-	0	30%	0.3
6REZ_LFA_D_301	10%	83%	0.378	0.907	0.3	0.48	-	-	0	85%	0.85
6REZ_LFA_D_304	9%	84%	0.318	0.853	0.3	0.46	-	-	0	80%	0.8
6REZ_LFA_C_304	9%	89%	0.203	0.823	0.29	0.35	-	-	0	25%	0.25
6REZ_LFA_D_303	8%	89%	0.202	0.808	0.3	0.33	-	-	0	25%	0.25
6REZ_LFA_E_306	8%	84%	0.297	0.814	0.32	0.44	-	-	0	75%	0.75
6REZ_LFA_E_301	7%	85%	0.388	0.891	0.35	0.39	-	-	0	75%	0.75
6REZ_LFA_A_306	6%	84%	0.329	0.807	0.31	0.44	-	-	0	75%	0.75
6REZ_LFA_B_305	6%	86%	0.205	0.715	0.3	0.42	-	-	0	50%	0.5
6REZ_LFA_A_307	4%	90%	0.323	0.807	0.32	0.28	-	-	0	35%	0.35
6REZ_LFA_C_308	3%	90%	0.323	0.757	0.33	0.29	-	-	0	35%	0.35
6REZ_LFA_B_304	2%	90%	0.339	0.726	0.29	0.33	-	-	0	25%	0.25
6REZ_LFA_B_307	0%	83%	0.849	0.843	0.33	0.45	-	-	0	80%	0.8
6REZ_LFA_E_302	0%	83%	0.888	0.862	0.3	0.48	-	-	0	80%	0.8
6REZ_LFA_C_307	0%	83%	0.85	0.764	0.3	0.47	-	-	0	85%	0.85
6REZ_LFA_A_302	0%	85%	0.903	0.804	0.33	0.41	-	-	0	80%	0.8
6REZ_LFA_D_306	0%	84%	1.07	0.846	0.33	0.43	-	-	0	80%	0.8
6RF6_LFA_A_307	50%	79%	0.101	0.904	0.23	0.62	-	-	0	70%	0.7
4XTL_LFA_A_315	46%	89%	0.079	0.949	0.26	0.38	-	-	1	25%	0.25
4XTN_LFA_J_311	43%	74%	0.092	0.958	0.38	0.61	-	-	1	20%	0.2
6XYT_LFA_C_309	41%	100%	0.165	0.878	0.07	0.05	-	-	0	100%	1
6RFC_LFA_A_336	39%	87%	0.105	0.92	0.24	0.46	-	-	0	40%	0.4
6SU4_LFA_X_616	66%	100%	0.113	0.917	0.09	0.1	-	-	0	100%	1
7AKY_LFA_A_403	58%	99%	0.088	0.911	0.08	0.14	-	-	5	75%	0.75
8QLF_LFA_A_408	55%	100%	0.083	0.933	0.1	0.06	-	-	1	55%	0.55
4HYJ_LFA_B_302	48%	74%	0.164	0.962	0.2	0.79	-	-	1	70%	0.7
7Z09_LFA_A_801	40%	75%	0.087	0.914	0.37	0.58	-	-	1	35%	0.35

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.

Prepare Data

Validate Data

Deposit Data

Help and Resources

6REZ

LFA: EICOSANE

LFA is a Ligand Of Interest in 6REZ designated by the RCSB